Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 48 (4) , 511-519
- https://doi.org/10.1016/s0026-0495(99)90113-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndromeFertility and Sterility, 1998
- Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 1997
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- The Role of Insulin Resistance in Polycystic Ovary SyndromeThe Endocrinologist, 1996
- Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese womenJournal of Clinical Endocrinology & Metabolism, 1995
- Cardiovascular Disease Risks, Insulin Resistance, and Androgen ExcessSeminars in Reproductive Medicine, 1994
- Molecular Mechanisms of Insulin Resistance in the Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 1994
- Lack of linear relationship between hyperinsulinaemia and hyperandrogenismClinical Endocrinology, 1992
- POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVEClinical Endocrinology, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988